Important Safety Information
If you have a pelvic or genital infection, get infections easily, or have certain cancers, don’t use Skyla. Less than 1% of users get a serious pelvic infection called pelvic inflammatory disease (PID). If you have persistent pelvic or stomach pain, or excessive bleeding after placement tell your healthcare provider (HCP). ...Continue reading below

Imprint

Supplier:

Bayer AG, Pharmaceuticals, Berlin, Germany

Represented by the Management Board:
Werner Baumann, Chairman
Liam Condon, Hartmut Klusik, Kemal Malik,
Wolfgang Nickl, Stefan Oelrich, Heiko Schipper

Müllerstrasse 178
Germany-13353 Berlin
phone: +49-30-468-11 11
for E-mail contact please click here .

Entry in the Commercial Register of the Cologne District Court (Amtsgericht): HRB 48248
Turnover tax ID no.: DE 123659859

Edited by:

Bayer AG
Strategic Marketing, Pharmaceuticals
13353 Berlin
Germany